NASDAQ
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...
ICU Medical, Inc. to Present at Two Upcoming Investor Conferences
SAN CLEMENTE, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a ...
ICU Medical, Inc. to Present at Two Upcoming Investor Conferences
SAN CLEMENTE, Calif., Feb. 24, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a ...
BeyondSpring Pharmaceuticals to Present Today at 4th Annual Cancer Biopartnering & Investment Forum in NYC
NEW YORK, Feb. 24, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage ...
ZIOPHARM Announces First Patient Treated in the Dose Escalation Portion of the Phase 1 Study of Ad-RTS-hIL-12 for Advanced Glioma
BOSTON, Feb. 24, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...
ADMA Biologics Recognized as One of New Jersey’s “Best Places to Work 2016”
RAMSEY, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage ...
‘Time is short’: Global Health NGO Urges Congress to Fund President’s Zika Request
MILLWOOD, Va., Feb. 23, 2016 (GLOBE NEWSWIRE) -- The head of the global health ...
CoLucid Pharmaceuticals Announces Confirmatory Support for Non-vasoconstrictive Mechanism of Action for Lasmiditan
CAMBRIDGE, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), a Phase 3 ...
Intercept Pharmaceuticals Reports 2015 Financial Results and Provides Business Update
NEW YORK, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical ...
BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ...
ZIOPHARM Announces Publication in Scientific Reports Describing Genetic Editing of Human Leukocyte Antigen in Cell Therapies to Broaden Their Human Application
BOSTON, Feb. 23, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...
Myriad Genetics Expands Strategic Research Collaboration With AbbVie
SALT LAKE CITY, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...
Oryzon to Attend the 36th Annual Cowen Health Care Conference
BARCELONA, Spain and CAMBRIDGE, Mass., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN ...